T1	Participants 84 128	patients with metastatic malignant melanoma.
T2	Participants 552 584	patients with malignant melanoma
T3	Participants 733 792	53 patients were stratified according to performance status
T4	Participants 2115 2147	patients with malignant melanoma
T5	Participants 2332 2364	patients with malignant melanoma
